Retinal cholinergic and dopaminergic deficits of aged rats are improved following treatment with GM1 ganglioside

被引:4
|
作者
Goettl, VM
Wemlinger, TA
Fong, TG
Neff, NH
Hadjiconstantinou, M [1 ]
机构
[1] Ohio State Univ, Coll Med & Publ Hlth, Dept Pharmacol, Columbus, OH 43210 USA
[2] Ohio State Univ, Coll Med & Publ Hlth, Dept Psychiat, Columbus, OH 43210 USA
关键词
retina; aging; dopamine; tyrosine hydroxylase; mazindol binding; choline acetyltransferase; hemicholinium-3; binding; GM1; ganglioside;
D O I
10.1016/S0006-8993(00)02598-1
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Selected cholinergic and dopaminergic markers were compared in the retina of aged (20-22-months-old) and young (3-months-old) rats before and after treatment with GM1 ganglioside. The dopaminergic markers, tyrosine hydroxylase, aromatic L-amino acid decarboxylase, dopamine, 3,4-dihydroxyphenylacetic acid and homovanillic acid were comparable in the young and aged animals and GM1 treatment did not alter them. In contrast, mazindol binding, a marker fur the dopamine transporter, was diminished in the aged retina and treatment with GM1 restored binding to values found in the young animals. The cholinergic markers choline acetyltransferase and hemicholinium-3 binding, a marker for the high-affinity choline transport, were depressed in aged rats and GM1 corrected the deficits. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 50 条
  • [31] Ganglioside GM1 potentiates NGF action on axotomised medial septal cholinergic neurons
    Panni, MK
    Cooper, JD
    Sofroniew, MV
    BRAIN RESEARCH, 1998, 812 (1-2) : 76 - 80
  • [32] GANGLIOSIDE GM1 DOES NOT PROMOTE NEURONAL SURVIVAL IN AXOTOMIZED FOREBRAIN CHOLINERGIC NEURONS
    HSIAO, NM
    FERRIS, T
    CLINICAL RESEARCH, 1993, 41 (01): : A52 - A52
  • [33] DIFFERENTIAL RECOVERY OF DOPAMINE SYNTHETIC ENZYMES FOLLOWING MPTP AND THE CONSEQUENCES OF GM1 GANGLIOSIDE TREATMENT
    HADJICONSTANTINOU, M
    NEFF, NH
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 181 (1-2) : 137 - 139
  • [34] Exogenous GM1 ganglioside increases accumbal BDNF levels in rats
    Valdomero, Analia
    Perondi, Maria C.
    Orsingher, Otto A.
    Cuadra, Gabriel R.
    BEHAVIOURAL BRAIN RESEARCH, 2015, 278 : 303 - 306
  • [35] Motoric behavior in aged rats treated with GM1
    Goettl, VM
    Wemlinger, TA
    Colvin, AE
    Neff, NH
    Hadjiconstantinou, M
    BRAIN RESEARCH, 2001, 906 (1-2) : 92 - 100
  • [36] GM1 ganglioside reverses the cognitive deficits induced by MK801 in mice
    Ni, Yu-Fei
    Zhang, Wei
    Bao, Xiao-Feng
    Wang, Wei
    Song, Lu
    Jiang, Bo
    BEHAVIOURAL PHARMACOLOGY, 2016, 27 (05): : 451 - 459
  • [37] GM1 GANGLIOSIDE TREATMENT REDUCES VISUAL DEFICITS AFTER GRADED CRUSH OF THE RAT OPTIC-NERVE
    SAUTTER, J
    SCHWARTZ, M
    DUVDEVANI, R
    SABEL, BA
    BRAIN RESEARCH, 1991, 565 (01) : 23 - 33
  • [38] RECOVERY FROM EXPERIMENTAL PARKINSONISM IN PRIMATES WITH GM1 GANGLIOSIDE TREATMENT
    SCHNEIDER, JS
    POPE, A
    SIMPSON, K
    TAGGART, J
    SMITH, MG
    DISTEFANO, L
    SCIENCE, 1992, 256 (5058) : 843 - 846
  • [39] MORPHINE-TOLERANCE IS INHIBITED BY CHRONIC TREATMENT WITH GM1 GANGLIOSIDE
    MALCANGIO, M
    PIZZIGHELLI, L
    GHELARDINI, C
    MALMBERGAIELLO, P
    TOFFANO, G
    GIOTTI, A
    BARTOLINI, A
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 183 (03) : 977 - 977
  • [40] EFFECT OF GM1 GANGLIOSIDE TREATMENT ON THE RECOVERY OF DOPAMINERGIC NIGRO-STRIATAL NEURONS AFTER DIFFERENT TYPES OF LESION
    TOFFANO, G
    AGNATI, LF
    FUXE, K
    ALDINIO, C
    CONSOLAZIONE, A
    VALENTI, G
    SAVOINI, G
    ACTA PHYSIOLOGICA SCANDINAVICA, 1984, 122 (03): : 313 - 321